Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the quit smoking drugs market?

The market size for anti-smoking medications has seen accelerated growth in the recent past. The market’s valuation is predicted to climb from $39.26 billion in 2024 to $44.62 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.7%. The upswing during the historic period can be credited to factors such as health enlightenment movements, advancements in the medical field, government-led incentives, incorporation of behavioral treatments, and modifications in consumer behaviors.

What will be the quit smoking drugs market size in the future?

The market size for anti-smoking medications is predicted to experience quick expansion in the upcoming years, with expectations of reaching a value of $79.99 billion in 2029, marking a compound annual growth rate (CAGR) of 15.7%. Factors contributing to this projected upswing during the forecast period include investment in research and development, a rising demand for cessation aids, targeted advertising and awareness drives, and advancements in pharmacotherapy. During this period, major market trends are anticipated to include individualized treatment procedures, growing health awareness, the rise of digital therapeutics and applications, inclusion of behavioral therapy, along with targeted marketing and education.

Get your quit smoking drugs market report here!

https://www.thebusinessresearchcompany.com/report/quit-smoking-drugs-global-market-report

What main drivers are fueling expansion in the quit smoking drugs market?

The escalating incidence of smoking addiction is anticipated to fuel the expansion of the quit-smoking drug market in the future. Smoking denotes the act of breathing in and out the fumes of burnt plant substances like marijuana, hashish, tobacco, etc. Quit-smoking medications aim to curb the desire to smoke by disrupting an individual’s craving for tobacco. This solution acts as a prescribed drug to manage nicotine withdrawal symptoms and facilitate successful cessation of smoking. For instance, in July 2022, Statistics Canada, a government body in Canada, revealed that the production of cigarettes had seen a surge of 5.8% in comparison to June 2021. Furthermore, the total cigarette sales witnessed a growth of 1.3% from May 2022, hitting 1.4 billion in June 2022. Consequently, the increasing prevalence of smoking addiction is boosting the development of the quit-smoking drug market.

What key areas define the segmentation of the global quit smoking drugs market?

The quit smoking drugs market covered in this report is segmented –

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets

2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs

3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)

2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems

3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers

4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges

5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9247&type=smp

Who are the dominant players expanding their reach in the quit smoking drugs market?

Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy’s Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.

How are evolving market trends shaping quit smoking drugs Strategies?

Propelling advancements in products is a major trend facilitating growth in the cease-smoking medication industry. Leading businesses in the stop-smoking drug market are centred on creating innovative products to reinforce their market presence. For example, in August 2022, Swedish Match AB, a tobacco corporation based in Sweden, announced the debut of its ZYN Tobacco Gold, a travel retail nicotine pouch with a tobacco flavor. Offered in medium (3 mg) and strong (6 mg) categories, the pouches carry a sweet tobacco flavor blending notes of dried fruit, wood, and caramel, which meets customer preferences as tobacco has become the most favored assistive flavor in choosing decreased-risk alternatives that don’t need tobacco or smoke. This is seen as a potential answer for those wishing to avoid tobacco while savoring nicotine in smoke-free settings.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9247

Which regions are emerging as leaders in the quit smoking drugs market?

North America was the largest region in the quit smoking drugs market in 2024. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Central Nervous System Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

Hematology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: